Patent · US Active

Small molecular inhibitors of RAD51 recombinase and methods thereof

US9216177B2 · kind B2 · utility

0Cited by
3References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 15, 2012
Grant dateDec 22, 2015
Priority date
Expiry dateFeb 15, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61N2005/1098
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention includes compositions comprising a selective small-molecule inhibitor of RAD51 recombinase and a pharmaceutically acceptable carrier. The invention further includes methods of treating or preventing cancer in a subject, comprising the step of administering to the subject the compositions contemplated within the invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.